Socio-demographic characteristics of the cases and controls, multi-centric case-control study of post-COVID rhino-orbito-cerebral mucormycosis, India, 2021. by Manickam Ponnaiah (294619)

Subjects:

PEER and RRR associated with an increase in Hb ≥1 g/dL. by Frédéric Galacteros (11105678)

Estimated number (in millions) of uncomplicated malaria cases per sub-population at increased risk of sub-optimal dosing. by Abena Takyi (17537340)

CYP2R1, CYP27B1, CYP24A1, and <i>DBP</i> (GC) SNPs, their minor allele frequencies, and HWE p-value in cases and controls. by Laith AL-Eitan (6841382)

Case 1 (A and B): After the treatment (24 doses of MDT), neural branches with an intense peri and endoneural lymphohistiocytic inflammatory process were observed (A) (→). by Andrea Maia Fernandes de Araújo Fonseca (10333122)

Subjects:

The base case analysis. by Wenwang Lang (20293527)

“…</p><p>Results</p><p>In the base-case scenario, adding benmelstobart and anlotinib to chemotherapy increased QALYs by 0.34 at an additional cost of $24,684.07, yielding an ICER of $71,559.84 per QALY. …”

Scaled, pairwise relative Weighted Interval Score (rWIS; see <i>Methods</i> for description) by location for national and state/territory/DC forecasts, averaged across all horizons... by Velma K. Lopez (18510171)

Scaled, pairwise relative Weighted Interval Score (rWIS) (see <i>Methods</i> for description) by spatial scale for sets of team forecasts that submitted forecasts for the US nation... by Velma K. Lopez (18510171)

Percent of weeks with complete submissions for all sets of team forecasts, scaled, pairwise relative Weighted Interval Score (rWIS; see <i>Methods</i> for description), observed 95... by Velma K. Lopez (18510171)

Genetic models and distributions of SNPs within (<i>CYP2R1, CYP27B1, CYP24A1,</i> and <i>DBP</i>) genes in 192 cases and 196 controls. by Laith AL-Eitan (6841382)

Receiver operating characteristic analysis of postoperative blood transfusion versus case start, performed on both the 15:00 discretization and the raw surgical case start time. by Ziyad O. Knio (4413460)

Subjects:

Fig 1 - by Erika Renzi (14078649)

Subjects:

Mechanisms through which IAS may increase disease risk: Real-case examples. by Eleonora Chinchio (9553057)

Fluctuation sources for case 3. by Mahmoud M. Hussein (16965014)

Genetic and clinical data for 24 probands with congenital hyperinsulinism and variants in a known hyperinsulinism gene. by Gabriela Pacheco (21738836)

Subjects:

Summary of the impact of mass gatherings (after the relaxation of social distancing policy) on the increase of new cases during the 10-day and 30-day periods after intervention, ta... by Pengyu Zhu (1819939)

Subjects:

Pathological data of the studied cases. by Sara Abdelal Mohammed (15306908)

Outcome and incidence of complication in our population (data are reported as number of cases and percentage in brackets). by Francesco D’Ambrosi (11944353)

Subjects:

Absence of haptoglobin increase in the first 34 weeks of 2020 in the US cohort. by Thierry Poynard (38084)

The topology of the case studies. by Emad S. Hassan (17775798)